Pre and Post Operative Care Flashcards
What is the Role of The Pharmacist in Pre and Post Operative Care?
- Complete an accurate Medication History of the patients pre-admission
- Work with the anaesthetist and the surgical team to make decisions on whether medications should be held or continued prior to surgery
- Educate and if necessary organise the patients medication regimen pre-operatively (Webster Pack, Nursing home resident)
Pre-Operative Care – Anti-coagulation and Anti-platelets
- What is there a balance between?
- Patients are classed as what and how is this measured?
- What other input may be required?
- Balance between bleeding risk and thromboembolic complications
- Class patient as ‘high risk’ or ‘low risk’ for thromboembolism
- Guides decision as whether to hold anti-coagulation or if bridging therapy is required
- Tools: CHA2DS2VASc, HAS-BLED
- Haematology input may be required e.g. if a patient who has previously had heparin induced thrombocytopenia
Pre-Operative Care – Anti-coagulation and Anti-platelets
- What are the Guidelines for High Risk Patients?
- Warfarin held for?
- Enoxaparin initiated for?
- What must be assessed before initiating?
- Last dose of enoxaparin before surgery?
- What needs to be checked the morning of procedure?
- If INR > 1.5?
- Hold warfarin 5 days prior to procedure
- Initiate enoxaparin 3 days before surgery
- Assess the patients estimated CrCl before recommending a dose
- Last dose of enoxaparin to be given 24hrs pre-operatively at half therapeutic dose – patient will need education on when to cease the enoxaparin
- Check INR morning of procedure (aim INR <1.5) – patients bleeding risk reduced if INR <1.5
- If INR >1.5, vitamin K indicated
- Depending on the type and length of surgery, reversal of warfarin may be necessary even after holding for 5 days
- If INR >1.5, vitamin K indicated
Pre-Operative Care – Anti-coagulation and Anti-platelets
- What are the Guidelines for Low-Risk Patients?
- Is bridging therapy required?
- Warfarin held when?
- What needs to be checked?
- No bridging therapy required
- Hold warfarin for 5 days prior to procedure
- Check INR morning of procedure (aim INR <1.5)
- If INR >1.5, vitamin K indicated
Pre-Operative Care – Anti-coagulation and Anti-platelets
- Warfarin Post Surgery
- When can warfarin and enoxaparin be re-started?
- What must patients have?
- What needs to be monitored?
- When can enoxaparin cease?
- When can warfarin and enoxaparin be re-started?
- Warfarin and enoxaparin can usually be re-started 24-72 hrs post surgery
- Patients need to have adequate haemostasis (Hb, platelets, INR etc) – bloods monitored daily to ensure this
- Renal function monitored and enoxaparin dose adjusted accordingly
- Enoxaparin can cease when INR therapeutic
- Patients need to have adequate haemostasis (Hb, platelets, INR etc) – bloods monitored daily to ensure this
Pre-Operative Care – Anti-coagulation and Anti-platelets
- What risk must be reviewed to determine medication plan pre-operatively?
- What changes the length of time they need to be held compared to warfarin?
- What must be assessed?
- When can they be re-started?
- Minor procedures
- Major procedures
- Risk of bleeding vs thromboembolism must be reviewed to determine medication plan pre-operatively
- DOACs have shorter t1/2 lives compared to warfarin which changes the length of time they need to be held pre-operatively
- Renal function must be assessed
- If GFR >80mL/min allow >24hrs between last dose of DOAC and surgery
- Re-starting:
- 24 hrs post-surgery for minor procedures
- 48-72hrs for major procedures
Pre-Operative Care – Anti-coagulation and Anti-platelets
- Pre-operative Interruption of Anti-Platelets
- Low risk patients may need to hold?
- High risk patients may need to hold?
- Low-risk patients may need to hold anti-platelet therapy pre-operatively
- E.g. patients on anti-platelet therapy for secondary prevention of MI
- Hold anti-platelets 7 days pre-operatively
- High risk patients on dual anti-platelet therapy usually continue aspirin and hold second anti-platelet
Pre-Operative Care – Diabetes Medications
- Diabetes Medicine Management in the Pre-Operative Setting
- Diabetics have a high what? Following surgery?
- Hyperglycaemia increases patients risk of what?
- What measurement should all diabetics have taken pre-operatively?
- Insulin-dependent diabetics (both Type 1 and Type 2) should be scheduled what?
- Diabetics have a higher incidence of morbidity and mortality following surgery
- Hyperglycaemia increases the patients risk of post-operative complications e.g. post-op infection
- All diabetics should have their HbA1c taken pre-operatively. When HbA1c >8%, the procedure may need to be re-scheduled
- Insulin-dependent diabetics (both Type 1 and Type 2) should be scheduled first on the operating list
- Fasting and/or holding diabetes medication can lead to hypoglycaemia
Pre-Operative Care – Diabetes Medications
- What are the Guideline Recommendations for Metformin?
- When should it be held?
- What may it increase the risk of?
- Consider holding SR when?
- When can it be restarted?
- Hold morning of surgery – may increase risk of renal insufficiency and increase patients risk of lactic acidosis
- Consider holding SR preparations evening before surgery
- Can re-start post-operatively when CrCl > 30mL/min
Pre-Operative Care – Diabetes Medications
What are the Guideline Recommendations for Sulfonylureas?
- When is it held?
- Consider holding SR preparations when?
- Hold morning of surgery – patient will be fasting, therefore reduce risk of hypoglycaemia
- Consider holding slow release preparations evening before surgery
Pre-Operative Care – Diabetes Medications
What are the Guideline Recommendations for GLP-1 analogues (exenatide, liraglutide)?
- When is it held and restarted?
- What are known adverse effects?
- Hold morning of surgery – restart when patient eating and drinking again post-operatively
- Known adverse effects of GLP-1 analogues are GI upset and delayed gastric emptying
Pre-Operative Care – Diabetes Medications
What are the Guideline Recommendations for Thiazolidinediones (rosiglitazone, pioglitazone)?
- When is it held?
- What can it contribute to?
- Hold morning of surgery
- Can contribute to fluid retention
Pre-Operative Care – Diabetes Medications
What are the Guideline Recommendations for DPP-4 inhibitors (sitalgliptin)?
- When are they held?
- What are they restarted?
- Hold morning of surgery
- Can restart when patient eating and drinking again post-operatively
Pre-Operative Care – Diabetes Medications
What are the Guideline Recommendations for SGLT2 inhibitors?
- What are they associated with?
- Severe ketosis can occur when?
- When is it held?
- What was the previous recommendation?
- Associated euglycemic diabetic ketoacidosis
- Severe ketosis can occur when BGL < 16mmol/L
- Hold 3 days pre-op (48 hrs prior to the day of surgery – day of surgery = day 0)
- Previously the recommendation was to hold the morning of surgery
Pre-Operative Care – Diabetes Medications
What are the Guideline Recommendations for Pre-op Insulin Modification on the Day of Procedure?
- Long acting insulins?
- Ultra-short, short and intermediate acting insulins?
- Long-acting insulins can be halved or held the evening prior and morning of surgery
- Ultra-short, short and intermediate acting insulins can be held morning of surgery